[1] LIU M H, DEVLIN J C, HU J Y, et al.Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and disease[J].eLife, 2021, 10:e63642.
[2] WITTING C, LANGMAN C B, ASSIMOS D, et al.Pathophysiology and treatment of enteric hyperoxaluria[J].Clinical Journal of the American Society of Nephrology, 2021, 16(3):487-495.
[3] LIESKE J C, MEHTA R A, MILLINER D S, et al.Kidney stones are common after bariatric surgery[J].Kidney International, 2015, 87(4):839-845.
[4] MITCHELL T, KUMAR P, REDDY T, et al.Dietary oxalate and kidney stone formation[J].American Journal of Physiology.Renal Physiology, 2019, 316(3):F409-F413.
[5] CIL O, CHU T, LEE S J, et al.Small-molecule inhibitor of intestinal anion exchanger SLC26A3 for treatment of hyperoxaluria and nephrolithiasis[J].JCI Insight, 2022, 7(13):e153359.
[6] CANALES B K, HATCH M.Kidney stone incidence and metabolic urinary changes after modern bariatric surgery:Review of clinical studies, experimental models, and prevention strategies[J].Surgery for Obesity and Related Diseases:Official Journal of the American Society for Bariatric Surgery, 2014, 10(4):734-742.
[7] HOLMES R P, KNIGHT J, ASSIMOS D G.Lowering urinary oxalate excretion to decrease calcium oxalate stone disease[J].Urolithiasis, 2016, 44(1):27-32.
[8] XU L H R, ADAMS-HUET B, POINDEXTER J R, et al.Temporal changes in kidney stone composition and in risk factors predisposing to stone formation[J].The Journal of Urology, 2017, 197(6):1 465-1 471.
[9] LIESKE J C, PEÑA DE LA VEGA L S, SLEZAK J M, et al.Renal stone epidemiology in Rochester, Minnesota:An update[J].Kidney International, 2006, 69(4):760-764.
[10] LAMINSKI N A, MEYERS A M, KRUGER M, et al.Hyperoxaluria in patients with recurrent calcium oxalate calculi:Dietary and other risk factors[J].British Journal of Urology, 1991, 68(5):454-458.
[11] HOLMES R P, GOODMAN H O, ASSIMOS D G.Contribution of dietary oxalate to urinary oxalate excretion[J].Kidney International, 2001, 59(1):270-276.
[12] WEI Z T, CUI Y Q, TIAN L, et al.Probiotic Lactiplantibacillus plantarum N-1 could prevent ethylene glycol-induced kidney stones by regulating gut microbiota and enhancing intestinal barrier function[J].FASEB Journal:Official Publication of the Federation of American Societies for Experimental Biology, 2021, 35(11):e21937.
[13] HATCH M, GJYMISHKA A, SALIDO E C, et al.Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter[J].American Journal of Physiology.Gastrointestinal and Liver Physiology, 2011, 300(3):G461-G469.
[14] HATCH M, CORNELIUS J, ALLISON M, et al.Oxalobacter sp.reduces urinary oxalate excretion by promoting enteric oxalate secretion[J].Kidney International, 2006, 69(4):691-698.
[15] MIKAMI K, AKAKURA K, TAKEI K, et al.Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation[J].International Journal of Urology, 2003, 10(6):293-296.
[16] SIDHU H, ALLISON M J, MAY CHOW J O, et al.Rapid reversal of hyperoxaluria in a rat model after probiotic administration of oxalobacter formigenes[J].The Journal of Urology, 2001, 166(4):1 487-1 491.
[17] SIENER R, BANGEN U, SIDHU H, et al.The role of Oxalobacter formigenes colonization in calcium oxalate stone disease[J].Kidney International, 2013, 83(6):1 144-1 149.
[18] ALLISON M J, DAWSON K A, MAYBERRY W R, et al.Oxalobacter formigenes Gen.nov., sp.nov.:Oxalate-degrading anaerobes that inhabit the gastrointestinal tract[J].Archives of Microbiology, 1985, 141(1):1-7.
[19] TURRONI S, VITALI B, BENDAZZOLI C, et al.Oxalate consumption by lactobacilli:Evaluation of oxalyl‐CoA decarboxylase and formyl‐CoA transferase activity in Lactobacillus acidophilus[J].Journal of Applied Microbiology, 2007, 103(5):1 600-1 609.
[20] HOKAMA S, HONMA Y, TOMA C, et al.Oxalate-degrading Enterococcus faecalis[J].Microbiology and Immunology, 2000, 44(4):235-240.
[21] TURRONI S, BENDAZZOLI C, DIPALO S C, et al.Oxalate-degrading activity in Bifidobacterium animalis subsp.lactis:Impact of acidic conditions on the transcriptional levels of the oxalyl coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes[J].Applied and Environmental Microbiology, 2010, 76(16):5 609-5 620.
[22] FEDERICI F, VITALI B, GOTTI R, et al.Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis[J].Applied and Environmental Microbiology, 2004, 70(9):5 066-5 073.
[23] HOKAMA S, TOMA C, IWANAGA M, et al.Oxalate-degrading Providencia rettgeri isolated from human stools[J].International Journal of Urology:Official Journal of the Japanese Urological Association, 2005, 12(6):533-538.
[24] FATAHI S, HOSSEINI A, SOHOULI M H, et al.Effects of probiotic supplementation on abdominal pain severity in pediatric patients with irritable bowel syndrome:A systematic review and meta-analysis of randomized clinical trials[J].World Journal of Pediatrics, 2022, 18(5):320-332.
[25] ALGIERI F, GARRIDO-MESA J, VEZZA T, et al.Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs[J].European Journal of Nutrition, 2021, 60(5):2 537-2 551.
[26] ASO Y, AKAZA H, KOTAKE T, et al.Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial.The BLP Study Group[J].European Urology, 1995, 27(2):104-109.
[27] CAMPIERI C, CAMPIERI M, BERTUZZI V, et al.Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration[J].Kidney International, 2001, 60(3):1 097-1 105.
[28] OKOMBO J, LIEBMAN M.Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects[J].Urological Research, 2010, 38(3):169-178.
[29] LIESKE J C, GOLDFARB D S, DE SIMONE C, et al.Use of a probioitic to decrease enteric hyperoxaluria[J].Kidney International, 2005, 68(3):1 244-1 249.
[30] MURPHY C, MURPHY S, O’BRIEN F, et al.Metabolic activity of probiotics—Oxalate degradation[J].Veterinary Microbiology, 2009, 136(1-2):100-107.
[31] ZHENG L, KELLY C J, COLGAN S P.Physiologic hypoxia and oxygen homeostasis in the healthy intestine.A Review in the Theme:Cellular Responses to Hypoxia[J].American Journal of Physiology.Cell Physiology, 2015, 309(6):C350-C360.
[32] FURNESS J B, CALLAGHAN B P, RIVERA L R, et al.The enteric nervous system and gastrointestinal innervation:Integrated local and central control[J].Advances in Experimental Medicine and Biology, 2014, 817:39-71.
[33] LEVY M, BLACHER E, ELINAV E.Microbiome, metabolites and host immunity[J].Current Opinion in Microbiology, 2017, 35:8-15.
[34] LYNCH S V, PEDERSEN O.The human intestinal microbiome in health and disease[J].The New England Journal of Medicine, 2016, 375(24):2 369-2 379.
[35] MEIJERS B K I, EVENEPOEL P.The gut-kidney axis:Indoxyl sulfate, p-cresyl sulfate and CKD progression[J].Nephrology Dialysis Transplantation, 2011, 26(3):759-761.
[36] STERN J M, MOAZAMI S, QIU Y P, et al.Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers[J].Urolithiasis, 2016, 44(5):399-407.
[37] TICINESI A, NOUVENNE A, CHIUSSI G, et al.Calcium oxalate nephrolithiasis and gut microbiota:Not just a gut-kidney axis.A nutritional perspective[J].Nutrients, 2020, 12(2):548.
[38] TICINESI A, MILANI C, GUERRA A, et al.Understanding the gut-kidney axis in nephrolithiasis:An analysis of the gut microbiota composition and functionality of stone formers[J].Gut, 2018, 67(12):2 097-2 106.
[39] TANG R Q, JIANG Y H, TAN A H, et al.16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stones[J].Urolithiasis, 2018, 46(6):503-514.
[40] ZHU H, CAO C J, WU Z C, et al.The probiotic L.casei Zhang slows the progression of acute and chronic kidney disease[J].Cell Metabolism, 2021, 33(10):1 926-1 942.
[41] FELIZARDO R J F, WATANABE I K M, DARDI P, et al.The interplay among gut microbiota, hypertension and kidney diseases:The role of short-chain fatty acids[J].Pharmacological Research, 2019, 141:366-377.
[42] PLATA C, CRUZ C, CERVANTES L G, et al.The gut microbiota and its relationship with chronic kidney disease[J].International Urology and Nephrology, 2019, 51(12):2 209-2 226.
[43] CAGGIANO G, COSOLA C, LEO V D, et al.Microbiome modulation to correct uremic toxins and to preserve kidney functions[J].Current Opinion in Nephrology and Hypertension, 2020, 29(1):49-56.
[44] MILLER A W, OAKESON K F, DALE C, et al.Microbial community transplant results in increased and long-term oxalate degradation[J].Microbial Ecology, 2016, 72(2):470-478.
[45] HAN C, JIANG Y H, LI W, et al.Astragalus membranaceus and Salvia miltiorrhiza ameliorates cyclosporin A-induced chronic nephrotoxicity through the “gut-kidney axis”[J].Journal of Ethnopharmacology, 2021, 269:113768.
[46] LIU Y, JIN X, MA Y C, et al.Short-chain fatty acids reduced renal calcium oxalate stones by regulating the expression of intestinal oxalate transporter SLC26A6[J].mSystems, 2021, 6(6):e0104521.
[47] SOLIMAN N R, EFFAT B A M, MEHANNA N S, et al.Activity of probiotics from food origin for oxalate degradation[J].Archives of Microbiology, 2021, 203(8):5 017-5 028.
[48] REN Z H, PAN C L, JIANG L Y, et al.Oxalate-degrading capacities of lactic acid bacteria in canine feces[J].Veterinary Microbiology, 2011, 152(3-4):368-373.
[49] KWAK C, JEONG B C, KU J H, et al.Prevention of nephrolithiasis by Lactobacillus in stone-forming rats:A preliminary study[J].Urological Research, 2006, 34(4):265-270.
[50] GOMATHI S, SASIKUMAR P, ANBAZHAGAN K, et al.Oral administration of indigenous oxalate degrading lactic acid bacteria and quercetin prevents calcium oxalate stone formation in rats fed with oxalate rich diet[J].Journal of Functional Foods, 2015, 17:43-54.
[51] MEHRA Y, RAJESH N G, VISWANATHAN P.Analysis and characterization of Lactobacillus paragasseri and Lacticaseibacillus paracasei:Two probiotic bacteria that can degrade intestinal oxalate in hyperoxaluric rats[J].Probiotics and Antimicrobial Proteins, 2022, 14(5):854-872.
[52] MEHRA Y, VISWANATHAN P.High-quality whole-genome sequence analysis of Lactobacillus paragasseri UBLG-36reveals oxalate-degrading potential of the strain[J].PLoS One, 2021, 16(11):e0260116.
[53] SASIKUMAR P, GOMATHI S, ANBAZHAGAN K, et al.Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats[J].Journal of Biomedical Science, 2014, 21(1):86.
[54] PAUL E, ALBERT A, PONNUSAMY S, et al.Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats[J].Microbiological Research, 2018, 215:65-75.
[55] ZHAO C M, YANG H, ZHU X J, et al.Oxalate-degrading enzyme recombined lactic acid bacteria strains reduce hyperoxaluria[J].Urology, 2018, 113:253.e1-253.e7.
[56] AFKARI R, FEIZABADI M M, ANSARI-MOGHADAM A, et al.Simultaneous use of oxalate-degrading bacteria and herbal extract to reduce the urinary oxalate in a rat model:A new strategy[J].International Braz J Urol:Official Journal of the Brazilian Society of Urology, 2019, 45(6):1 249-1 259.
[57] ZAMPINI A, NGUYEN A H, ROSE E, et al.Defining dysbiosis in patients with urolithiasis[J].Scientific Reports, 2019, 9(1):1-13.
[58] WANG L F, ZHANG J C, GUO Z, et al.Effect of oral consumption of probiotic Lactobacillus planatarum P-8 on fecal microbiota, SIgA, SCFAs, and TBAs of adults of different ages[J].Nutrition, 2014, 30(7-8):776-783.
[59] SIES H.Oxidative stress:A concept in redox biology and medicine[J].Redox Biology, 2015, 4:180-183.
[60] SCHEID C, KOUL H, HILL W A, et al.Oxalate toxicity in LLC-PK1 cells:Role of free radicals[J].Kidney International, 1996, 49(2):413-419.
[61] DAVALOS M, KONNO S, ESHGHI M, et al.Oxidative renal cell injury induced by calcium oxalate crystal and renoprotection with antioxidants:A possible role of oxidative stress in nephrolithiasis[J].Journal of Endourology, 2010, 24(3):339-345.
[62] KHAND F D, GORDGE M P, ROBERTSON W G, et al.Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells[J].Free Radical Biology and Medicine, 2002, 32(12):1 339-1 350.
[63] ITOH Y, YASUI T, OKADA A, et al.Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis[J].The Journal of Urology, 2005, 173(1):271-275.
[64] LI C Y, DENG Y L, SUN B H.Taurine protected kidney from oxidative injury through mitochondrial-linked pathway in a rat model of nephrolithiasis[J].Urological Research, 2009, 37(4):211-220.
[65] KULLISAAR T, ZILMER M, MIKELSAAR M, et al.Two antioxidative lactobacilli strains as promising probiotics[J].International Journal of Food Microbiology, 2002, 72(3):215-224.
[66] WANG Y, WU Y P, WANG Y Y, et al.Antioxidant properties of probiotic bacteria[J].Nutrients, 2017, 9(5):521.
[67] SASIKUMAR P, GOMATHI S, ANBAZHAGAN K, et al.Genetically engineered Lactobacillus plantarum WCFS1 constitutively secreting heterologous oxalate decarboxylase and degrading oxalate under in vitro[J].Current Microbiology, 2014, 69(5):708-715.
[68] KOLANDASWAMY A, GEORGE L, SADASIVAM S.Heterologous expression of oxalate decarboxylase in Lactobacillus plantarum NC8[J].Current Microbiology, 2009, 58(2):117-121.
[69] SASIKUMAR P, GOMATHI S, ANBAZHAGAN K, et al.Secretion of biologically active heterologous oxalate decarboxylase (OxdC) in Lactobacillus plantarum WCFS1 using homologous signal peptides[J].BioMed Research International, 2013, 2013:280432.
[70] ANBAZHAGAN K, SASIKUMAR P, GOMATHI S, et al.In vitro degradation of oxalate by recombinant Lactobacillus plantarum expressing heterologous oxalate decarboxylase[J].Journal of Applied Microbiology, 2013, 115(3):880-887.
[71] LUBKOWICZ D, HORVATH N G, JAMES M J, et al.An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria[J].Molecular Systems Biology, 2022, 18(3):e10539.
[72] LANGMAN C B, GRUJIC D, PEASE R M, et al.A double-blind, placebo controlled, randomized phase 1 cross-over study with ALLN-177, an orally administered oxalate degrading enzyme[J].American Journal of Nephrology, 2016, 44(2):150-158.
[73] LINGEMAN J E, PAREEK G, EASTER L, et al.ALLN-177, oral enzyme therapy for hyperoxaluria[J].International Urology and Nephrology, 2019, 51(4):601-608.
[74] LEE E, JEONG B C, PARK Y H, et al.Expression of the gene encoding oxalate decarboxylase from Bacillus subtilis and characterization of the recombinant enzyme[J].BMC Research Notes, 2014, 7:598.
